Hospital Drug Billing Added $12.7 Billion to Employer Costs

Employers and workers overpay for drugs when they are administered in hospital outpatient departments versus private offices.

Updated on Sept. 29, 2026 in Healthcare

Bold flat-color editorial illustration depicting a stylized, geometric medical office building, representing institutional healthcare billing structures. — Hospital outpatient departments charged $12.7 billion more in drug administration fees than physician offices, according to 2023-24 commercial claims data. AI Illustration. Upload story photo >

Live Poll

Do you trust that your health insurance costs accurately reflect the fair market price of care?

Research covering 2023-24 commercial claims found that hospital outpatient departments received 102% higher average payments for identical drugs than physician offices. This price disparity adds $12.7 billion in annual health spending for U.S. employers.

Why it matters

The payment gap increases operational overhead for businesses offering employer-sponsored health plans. Shifting administration to lower-cost settings could yield significant savings for both firms and their covered workers.

Analysis of 106 high-spending, physician-administered drugs showed that hospital outpatient departments received higher reimbursement for 93 of the medications studied. The median annual payment difference reached $5,531 per patient, with some oncology drugs seeing differences up to $135,306.

The details

The disparity arises because insurers often pay different rates for the same drug based on the site of service. Hospitals frequently charge facility fees on top of drug costs, while physician offices operate under a different reimbursement structure. Because 59% of these medication administrations occurred in hospital settings, these inflated costs significantly impact total employer benefit expenditures.

2019: Median hospital outpatient drug markup reached 98%.
2023-24: Data collection period for commercial claims.
2024: Median hospital outpatient drug markup reached 70%.
Sept. 28: Research findings were released.

Market Landscape

This disparity mirrors the long-standing site-of-service payment gap seen in federal programs like Medicare. It underscores the broader trend of consolidation in healthcare, where hospital-owned practices often command higher reimbursement rates than independent offices for identical procedures.

Employers should review their health plan designs to identify if they incentivize care in higher-cost hospital settings. Benefit managers can audit claims data to determine if steerage to independent physician offices for specialty drug administration could reduce annual costs by approximately $101 per member.

The takeaway

The data confirms that administrative site choice is a major driver of employer health spending volatility. Operators should work with their benefits consultants to evaluate whether current insurance contracts limit cost-effective site options for common drug infusions.